Trial Profile
Open label variable dose escitalopram (Lexapro) in the treatment of patients with postpartum major depression: a pilot study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Postnatal depression
- Focus Therapeutic Use
- 05 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2008 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 24 Oct 2006 New trial record.